Detalhe da pesquisa
1.
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(11): 1974-1982, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544285
2.
Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response.
Front Oncol
; 8: 669, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30697529
3.
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.
J Clin Med
; 4(4): 665-95, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25932335